Evidence map›Paper›PMID 40548736›Full record

ArticleMicrobiology spectrum2025

Heterogeneity of

Nancy E Scott, Elizabeth Wash, Christopher Zajac, Serin E Erayil, Susan E Kline, Anna Selmecki

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Micafungin exposure drives multidrug resistance inbioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Pathogens (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Nancy E ScottBioinformatics and Computational Biology Program, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0003-1678-0796
Elizabeth WashDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA.
Christopher ZajacDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA.
Serin E ErayilDepartment of Medicine, Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Susan E KlineDepartment of Medicine, Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Anna SelmeckiBioinformatics and Computational Biology Program, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0003-3298-2400

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UM1TR004405 · NCATS · UNIVERSITY OF MINNESOTA · PI Bruce R Blazar, Damien A Fair · 2023 to 2026
$30.8M
Aneuploidy and Acquired Antifungal Drug Resistance in Candida speciesR01AI143689 · NIAID · UNIVERSITY OF MINNESOTA · PI Anna M. Selmecki · 2020 to 2026
$3.2M
CTSA Predoctoral T32 at University of MinnesotaT32TR004385 · NCATS · UNIVERSITY OF MINNESOTA · PI Jayne Allyn Fulkerson · 2024 to 2026
$1.3M
Burroughs Wellcome Fund #1020388National Science Foundation DBI-232051NCATS NIH HHS T32 TR004385NCATS NIH HHS UM1 TR004405NIAID NIH HHS R01 AI143689NIH HHS R01AI143689University of Minnesota Graduate School Doctoral Dissertation Fellowship DDFUniversity of Minnesota Undergrad Research Opportunity UROP
6 · The paper itself

Abstract

Invasive

Indexed as

Antifungal AgentsCandidaCandidemiaAcademic Medical CentersAdultAgedDrug Resistance, FungalFemaleHospitalsHumansMaleMicrobial Sensitivity TestsMiddle AgedMinnesotaAntifungal Agentsantifungal drug resistancecandidemiaemerging Candida speciesserial isolates

Identifiers

PMID40548736
PMCPMC12323643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.